Innate Pharma SA Other Current Payables
Innate Pharma SA (IPHYF) had Other Current Payables of EUR 1.02 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:OtherCurrentPayables · last filed 2026-04-01
- 2025-12-31: Other Current Payables 1.02M EUR.
- 2025-06-30: Other Current Payables 897.00K EUR.
- 2024-12-31: Other Current Payables 1.12M EUR.
- 2024-06-30: Other Current Payables 1.11M EUR.
| Period end | Other Current Payables |
|---|---|
| 2025-12-31 | 1.02M EUR 20-F · filed 2026-04-01 |
| 2025-06-30 | 897.00K EUR 6-K · filed 2025-09-17 |
| 2024-12-31 | 1.12M EUR 20-F · filed 2026-04-01 |
| 2024-06-30 | 1.11M EUR 6-K · filed 2024-09-12 |
| 2023-12-31 | 1.44M EUR 20-F · filed 2026-04-01 |
| 2023-06-30 | 1.38M EUR 6-K · filed 2023-09-14 |
| 2022-12-31 | 1.26M EUR 20-F · filed 2025-04-30 |
| 2022-06-30 | 13.00K EUR 6-K · filed 2022-09-15 |
| 2021-12-31 | 6.38M EUR 20-F · filed 2024-04-04 |
| 2021-06-30 | 139.00K EUR 6-K · filed 2021-09-15 |
| 2020-12-31 | 463.00K EUR 20-F · filed 2023-04-06 |
| 2019-12-31 | 1.11M EUR 20-F · filed 2022-04-04 |
| 2018-12-31 | 425.00K EUR 20-F · filed 2021-04-27 |
| 2017-12-31 | 209.00K EUR 20-F · filed 2020-04-24 |